Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia: a randomized double-blind trial.

@article{Gattaz2004OlanzapineVF,
  title={Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia: a randomized double-blind trial.},
  author={Wagner F. Gattaz and Alexander Diehl and M S Geuppert and Petra Hubrich and Andrea Schmitt and Iris Linde and Athanasios Maras and Ralf Dittmann},
  journal={Pharmacopsychiatry},
  year={2004},
  volume={37 6},
  pages={279-85}
}
OBJECTIVE The atypical antipsychotic olanzapine has extensively been compared with haloperidol, whereas studies vs. other (conventional) neuroleptics are scarce. This exploratory double-blind 4-week study was designed to compare the efficacy and the safety of olanzapine (OLA) and flupenthixol (FLU) which have recently been considered as a "partially atypical" antipsychotics. METHODS Twenty-eight inpatients with schizophrenia (DSM-IV) were randomly assigned for treatment with OLA (N = 15, 5-20… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…